hotspot -WSS

hotspot

author：hotspot 2025-09-28 23:05:35 - browse：92872

When Prozac first entered the psychiatry scene in in the late ’80s, the profession was still Freud’s territory. Many considered taking medication to treat depression a failure. But that was all about to change, as early stewards like psychiatrist Peter Kramer refused to shy away from the new drug’s potential. These days, he says that people take for granted all of the progress that’s been made with antidepressant treatment in the past three decades.

“If you were going to be depressed any time in history and were interested in having an effective treatment, you would want to be alive now. But we’ve lost our wonderment about that,” said Kramer, the author of the groundbreaking 1993 book “Listening to Prozac.”

This week, Kramer joins me to discuss how the country’s relationship with antidepressants has changed since the publication of his book three decades ago. The conversation is based on his First Opinion, “What antidepressants are saying 30 years after the publication of ‘Listening to Prozac.’”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts. And don’t forget to sign up for the First Opinion newsletter to read each week’s best First Opinion essays.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： National panel will explore requiring free Covid tests

knowledge

WSS

New safety details link Apellis eye drug to rare cases of blindness

NIH launches clinical trials and new research office for long Covid

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Nurses recount patients attacks

Orchard's therapy for neuron disease in children wins FDA approval

Future doctors should be trained to promote social change

knowledge

hotspot

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Micronoma's microbiome cancer diagnostic approach under fire

Walensky prepares to leave CDC — and Congress — behind

‘Oppenheimer’ and the risks of AI in health care

Heart attack and stroke risk calculators need revising

SCOTUS questions limit to govt efforts to fight misinformation

At least 13 dead in Texas as scorching temps continue

‘Oppenheimer’ and the risks of AI in health care

Apple is now the first public company to be valued at $3 trillion

Future doctors should be trained to promote social change

entertainment

The high personal cost of affirmative action for Black doctors

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Mega Millions pot grows to $1.25 billion after no winner

Health AI adoption puts security, privacy startups on investors' radar

Stop the failed accountable care organization experiment

Sage hopes for a blockbuster in antidepressant now before FDA

leisure time

knowledge

hotspot

entertainment